Compare CMPX & MBWM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CMPX | MBWM |
|---|---|---|
| Founded | 2014 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 927.5M | 881.8M |
| IPO Year | 2020 | 1997 |
| Metric | CMPX | MBWM |
|---|---|---|
| Price | $1.91 | $52.01 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | $14.57 | ★ $55.67 |
| AVG Volume (30 Days) | ★ 10.8M | 97.6K |
| Earning Date | 05-06-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 3.08% |
| EPS Growth | N/A | ★ 10.95 |
| EPS | N/A | ★ 1.32 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $20.28 |
| Revenue Next Year | $934.41 | $4.67 |
| P/E Ratio | ★ N/A | $39.33 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.61 | $42.17 |
| 52 Week High | $6.88 | $55.77 |
| Indicator | CMPX | MBWM |
|---|---|---|
| Relative Strength Index (RSI) | 24.24 | 53.11 |
| Support Level | $1.61 | $47.78 |
| Resistance Level | $3.63 | $54.90 |
| Average True Range (ATR) | 0.38 | 1.49 |
| MACD | -0.26 | -0.01 |
| Stochastic Oscillator | 5.04 | 47.65 |
Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.
Mercantile Bank Corp operates as a bank holding company. It offers various commercial banking services to individuals, businesses, governmental units, and other institutions. These services include deposit products such as checking, savings, and term certificate accounts and lending products such as commercial, residential mortgage, and installment loans. The company generates revenue from interest and dividends earned on loans, securities, and other financial instruments.